Particle size, magnetic field, and blood velocity effects on particle retention in magnetic drug targeting

被引:68
作者
Cherry, Erica M. [1 ]
Maxim, Peter G. [2 ]
Eaton, John K. [1 ]
机构
[1] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA
[2] Stanford Univ, Dept Radiat Oncol, Stanford, CA 94305 USA
关键词
magnetic drug targeting; Helmoltz coils; electromagnet; magnetic field gradient; cancer; tumor; drug delivery; particle retention; LOCOREGIONAL CANCER-TREATMENT; IN-VITRO; NANOPARTICLES; DELIVERY; SYSTEMS; BIODISTRIBUTION; MICROSPHERES; CHEMOTHERAPY; HYPERTHERMIA; RELEASE;
D O I
10.1118/1.3271344
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
100231 [临床病理学]; 100902 [航空航天医学];
摘要
Purpose: A physics-based model of a general magnetic drug targeting (MDT) system was developed with the goal of realizing the practical limitations of MDT when electromagnets are the source of the magnetic field. Methods: The simulation tracks magnetic particles subject to gravity, drag force, magnetic force, and hydrodynamic lift in specified flow fields and external magnetic field distributions. A model problem was analyzed to determine the effect of drug particle size, blood flow velocity, and magnetic field gradient strength on efficiency in holding particles stationary in a laminar Poiseuille flow modeling blood flow in a medium-sized artery. Results: It was found that particle retention rate increased with increasing particle diameter and magnetic field gradient strength and decreased with increasing bulk flow velocity. Conclusions: The results suggest that MDT systems with electromagnets are unsuitable for use in small arteries because it is difficult to control particles smaller than about 20 mu m in diameter. (C) 2010 American Association of Physicists in Medicine. [DOI: 10.1118/1.3271344]
引用
收藏
页码:175 / 182
页数:8
相关论文
共 32 条
[1]
In vitro and in vivo investigations of targeted chemotherapy with magnetic nanoparticles [J].
Alexiou, C ;
Jurgons, R ;
Schmid, R ;
Hilpert, A ;
Bergemann, C ;
Parak, F ;
Iro, H .
JOURNAL OF MAGNETISM AND MAGNETIC MATERIALS, 2005, 293 (01) :389-393
[2]
Magnetic drug targeting - Biodistribution of the magnetic carrier and the chemotherapeutic agent mitoxantrone after locoregional cancer treatment [J].
Alexiou, C ;
Jurgons, R ;
Schmid, RJ ;
Bergemann, C ;
Henke, J ;
Erhardt, W ;
Huenges, E ;
Parak, F .
JOURNAL OF DRUG TARGETING, 2003, 11 (03) :139-149
[3]
Magnetic drug targeting: biodistribution and dependency on magnetic field strength [J].
Alexiou, C ;
Schmidt, A ;
Klein, R ;
Hulin, P ;
Bergemann, C ;
Arnold, W .
JOURNAL OF MAGNETISM AND MAGNETIC MATERIALS, 2002, 252 (1-3) :363-366
[4]
Alexiou C, 2000, CANCER RES, V60, P6641
[5]
Alexiou C, 2007, ANTICANCER RES, V27, P2019
[6]
A high field gradient magnet for magnetic drug targeting [J].
Alexiou, Christoph ;
Diehl, Dirk ;
Henninger, Peter ;
Iro, Heinrich ;
Roeckelein, Rudolf ;
Schmidt, Wolfgang ;
Weber, Horst .
IEEE TRANSACTIONS ON APPLIED SUPERCONDUCTIVITY, 2006, 16 (02) :1527-1530
[7]
Magnetic nanoparticles for drug delivery [J].
Arruebo, Manuel ;
Fernandez-Pacheco, Rodrigo ;
Ibarra, M. Ricardo ;
Santamaria, Jesus .
NANO TODAY, 2007, 2 (03) :22-32
[8]
In vitro study of magnetic particle seeding for implant assisted-magnetic drug targeting [J].
Aviles, Misael O. ;
Ebner, Armin D. ;
Ritter, James A. .
JOURNAL OF MAGNETISM AND MAGNETIC MATERIALS, 2008, 320 (21) :2640-2646
[9]
Babincová M, 2001, Z NATURFORSCH C, V56, P909
[10]
Babincová M, 2000, Z NATURFORSCH C, V55, P278